Co-Crystals in Enhancing Drug Solubility and Stability: A Comprehensive Review

Co-crystals are solid-state complexes formed by an active pharmaceutical ingredient (API) and a co-former in a defined stoichiometric ratio. They offer a promising strategy to address the challenges of poor solubility and stability in pharmaceutical formulations. This review delves into the mechanisms by which co-crystals improve drug solubility, enhance stability, and optimize bioavailability. We explore the different techniques used in co-crystal formation, their characterization, advantages over traditional formulations, and challenges in commercialization and regulatory approval. Additionally, we review case studies highlighting successful co-crystal applications and discuss future directions for research in the field. The insights provided in this paper offer a deeper understanding of co-crystal technology and its potential to revolutionize the pharmaceutical industry.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-14
DOI
https://doi.org/10.5281/zenodo.15400762
Primary Topic
Crystallography and molecular interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Co-Crystals in Enhancing Drug Solubility and Stability: A Comprehensive Review

Zenodo (CERN European Organization for Nuclear Research)
Crystallography and molecular interactions
article

Co-Crystals in Enhancing Drug Solubility and Stability: A Comprehensive Review

article en

Abstract

Co-crystals are solid-state complexes formed by an active pharmaceutical ingredient (API) and a co-former in a defined stoichiometric ratio. They offer a promising strategy to address the challenges of poor solubility and stability in pharmaceutical formulations. This review delves into the mechanisms by which co-crystals improve drug solubility, enhance stability, and optimize bioavailability. We explore the different techniques used in co-crystal formation, their characterization, advantages over traditional formulations, and challenges in commercialization and regulatory approval. Additionally, we review case studies highlighting successful co-crystal applications and discuss future directions for research in the field. The insights provided in this paper offer a deeper understanding of co-crystal technology and its potential to revolutionize the pharmaceutical industry.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 57%
Crystallography and molecular interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.